123i b-cit
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2000 (NCT00134784)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i b-cit
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00273351 | Phase 2 | Jan 1, 2006 | Department of Defense, Institute for Neurodegenerative Disorders, Molecular NeuroImaging |
| NCT00134784 | Phase 2 | Apr 1, 2000 | Department of Defense, Institute for Neurodegenerative Disorders |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 2 | 0 | 1 | 2000 |
| Institute for Neurodegenerative Disorders | Academic/Hospital | 2 | 2 | 1 | 2000 |
| Molecular NeuroImaging | For profit | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1